ImmuneOncia Therapeutics Inc. Company Profile, Contacts & Intelligence

ImmuneOncia Therapeutics Inc. Overview

ImmuneOncia is an immuno-oncology-centric biopharmaceutical company. Established in 2016 as a joint venture company between Yuhan and Sorrento, ImmuneOncia will leverage both companies’ expertise in drug development and antibody engineering. Our mission is to bring safe, effective, and novel immunotherapies to oncology patients world-wide. ImmuneOncia’s portfolio includes diverse immune checkpoint antibodies; the lead antibody IMC-001 Phase I study was completed in Feb 2019 and its Phase 2 study is being prepared. ImmuneOncia is also developing several antibodies targeting novel immune-checkpoints.

Headquarters

Kr

Website

www.immuneoncia.com

Industry

Pharmaceutical Manufacturing

Founded

2016

NAICS

Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing

Phone Number

Available in AeroLeads

Company Email

Available in AeroLeads

ImmuneOncia Therapeutics Inc. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

ImmuneOncia Therapeutics Inc. People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

ImmuneOncia Therapeutics Inc. Workforce Composition

Seniority breakdown across 11 visible profiles.

Compare Similar Companies to ImmuneOncia Therapeutics Inc.

Explore companies in related markets and compare their industry and employee estimates.